Keyphrases
Transcatheter Aortic Valve Replacement
100%
Risk Assessment
100%
Left Ventricular Systolic Dysfunction
100%
Cardiovascular Mortality
50%
Tricuspid Regurgitation
37%
Clinical Variables
25%
Confidence Interval
12%
Clinical Outcomes
12%
Multicenter Registry
12%
Valvular Interventions
12%
Severe Aortic Stenosis
12%
Left Ventricular Ejection Fraction
12%
Transcatheter
12%
85-year-old
12%
Post-procedural
12%
Patients with Heart Failure
12%
Heart Failure with Preserved Ejection Fraction (HFpEF)
12%
2-year Mortality
12%
Adjusted Hazard Ratio
12%
Systolic Dysfunction
12%
Background Mortality
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Mortality
100%
Tricuspid Valve Regurgitation
100%
Left Ventricular Systolic Dysfunction
100%
Aortic Stenosis
33%
Heart Failure with Reduced Ejection Fraction
33%
Systolic Dysfunction
33%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Left Ventricular Systolic Dysfunction
100%
Cardiovascular Mortality
33%
Tricuspid Insufficiency
33%
Cardiovascular System
11%
Valvular Intervention
11%
Aortic Stenosis
11%
Heart Left Ventricle Ejection Fraction
11%
Hazard Ratio
11%
Heart Failure with Reduced Ejection Fraction
11%
Systolic Dysfunction
11%